Skip to main content
. 2022 Dec 14;9:1068569. doi: 10.3389/fmed.2022.1068569

TABLE 4.

Secondary outcome.

Tracheostomy timing

Outcome ≤4 days 5–10 days ≥11 days P-value
In-ICU mortality, no. (%) 14 (8.6%) a 35 (8.8%) a 108 (16.7%) b <0.001
30-days mortality, no. (%) 16 (9.8%) a,b 41 (10.3%) b 110 (17%) a 0.003
Hospital LOS, median (IQR) 18.7 (12.8–29.5) 21.7 (15.1–30.2) 32.1 (24.4–43.8) <0.001
ICU LOS, median (IQR) 14.8 (7.7–24.0) 16.0 (12.1–23.6) 28.2 (21.7–38.0) <0.001
Length of MV, median (IQR) 8.4 (4.2–15.1) 11.5 (8.6–16.8) 22.3 (17.1–30.3) <0.001
MV free days, median (IQR) 4.6 (2.2–8.8) 4.1 (1.8–7.1) 4.2 (1.8–8.5) 0.414
Sedative days, median (IQR) 5.0 (3.0–9.0) 7.0 (4.0–10.0) 11.0 (6.0–17.0) <0.001
Analgesia days, median (IQR) 5.0 (3.0–10.0) 9.0 (5.0–13.0) 12.0 (6.0–21.0) <0.001
Sedation and analgesia free days, median (IQR) 6.9 (2.1–11.6) 7.0 (3.5–14.3) 13.5 (6.4–22.9) <0.001
VAP rate, n (%) 15 (9.2) a,b 49 (12.3) b 44 (6.8) a <0.001

IQR, interquartile range; MV, mechanical ventilation; LOS, length of stay; VAP, ventilator associated pulmonary. Corner markers a and b represent the results of multiple comparison. In each outcome, the same corner markers mean no statistical difference between the two groups, while different corner markers mean statistical difference between the two groups.